Immunogenicity and Safety of Yellow Fever Vaccination for 102 HIV‐Infected Patients

Open Access
Publisher Website
Google Scholar
Abstract
Background. Yellow fever vaccine (17DV) has been investigated incompletely in human immunodeficiency virus (HIV)-infected patients, and adequate immu